Cargando…
Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways
Background: Fifteen to 25-year-olds are the age group most likely to misuse prescription drugs. Few studies have tested theory-driven models of adolescent risk for prescription drug misuse. Moreover, rarely are distinct pathways to different forms of prescription drug misuse considered. Methods: We...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110923/ https://www.ncbi.nlm.nih.gov/pubmed/33986700 http://dx.doi.org/10.3389/fpsyt.2021.640766 |
_version_ | 1783690394487226368 |
---|---|
author | Stewart, Sherry H. Chinneck, Annie Thompson, Kara Afzali, Mohammad H. Nogueira-Arjona, Raquel Mahu, Ioan T. Conrod, Patricia J. |
author_facet | Stewart, Sherry H. Chinneck, Annie Thompson, Kara Afzali, Mohammad H. Nogueira-Arjona, Raquel Mahu, Ioan T. Conrod, Patricia J. |
author_sort | Stewart, Sherry H. |
collection | PubMed |
description | Background: Fifteen to 25-year-olds are the age group most likely to misuse prescription drugs. Few studies have tested theory-driven models of adolescent risk for prescription drug misuse. Moreover, rarely are distinct pathways to different forms of prescription drug misuse considered. Methods: We tested mediational paths from personality to mental health symptoms to prescription drug misuse, informed by etiological models of addiction. We specified pathways from particular personality traits to unique forms of prescription drug misuse via specific mental health symptoms. We used semi-longitudinal data collected across two waves of the Co-Venture Trial. Our sample included students from 31 Canadian high schools tested in Grade 9 (n = 3,024) and again in Grade 10 (n = 2,869; 95% retention). Personality (hopelessness, anxiety sensitivity, impulsivity, sensation seeking) was assessed in Grade 9. Mental health symptoms (depression, anxiety, ADHD, conduct disorder) and prescription drug misuse (opioids, sedatives/tranquilizers, stimulants) were assessed at both time points. Results: Consistent with the negative affect regulation model, hopelessness was specifically associated with opioid misuse via depressive symptoms, and anxiety sensitivity was specifically associated with sedative/tranquilizer misuse via anxiety symptoms. Consistent with positive affect regulation, sensation seeking was directly associated with stimulant misuse. Consistent with the psychological dysregulation model, impulsivity was associated with stimulant misuse via ADHD symptoms. And consistent with the deviance proneness model, impulsivity was also associated with unconstrained (i.e., all three forms of) prescription drug misuse via conduct disorder symptoms. Conclusions: Screening for adolescents high in hopelessness, anxiety sensitivity, sensation seeking, or impulsivity and providing them with personality-matched cognitive-behavioral interventions may be helpful in preventing or mitigating prescription drug misuse. Our results point to the specific mental health symptoms that are important to target in each of these personality-matched interventions. |
format | Online Article Text |
id | pubmed-8110923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81109232021-05-12 Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways Stewart, Sherry H. Chinneck, Annie Thompson, Kara Afzali, Mohammad H. Nogueira-Arjona, Raquel Mahu, Ioan T. Conrod, Patricia J. Front Psychiatry Psychiatry Background: Fifteen to 25-year-olds are the age group most likely to misuse prescription drugs. Few studies have tested theory-driven models of adolescent risk for prescription drug misuse. Moreover, rarely are distinct pathways to different forms of prescription drug misuse considered. Methods: We tested mediational paths from personality to mental health symptoms to prescription drug misuse, informed by etiological models of addiction. We specified pathways from particular personality traits to unique forms of prescription drug misuse via specific mental health symptoms. We used semi-longitudinal data collected across two waves of the Co-Venture Trial. Our sample included students from 31 Canadian high schools tested in Grade 9 (n = 3,024) and again in Grade 10 (n = 2,869; 95% retention). Personality (hopelessness, anxiety sensitivity, impulsivity, sensation seeking) was assessed in Grade 9. Mental health symptoms (depression, anxiety, ADHD, conduct disorder) and prescription drug misuse (opioids, sedatives/tranquilizers, stimulants) were assessed at both time points. Results: Consistent with the negative affect regulation model, hopelessness was specifically associated with opioid misuse via depressive symptoms, and anxiety sensitivity was specifically associated with sedative/tranquilizer misuse via anxiety symptoms. Consistent with positive affect regulation, sensation seeking was directly associated with stimulant misuse. Consistent with the psychological dysregulation model, impulsivity was associated with stimulant misuse via ADHD symptoms. And consistent with the deviance proneness model, impulsivity was also associated with unconstrained (i.e., all three forms of) prescription drug misuse via conduct disorder symptoms. Conclusions: Screening for adolescents high in hopelessness, anxiety sensitivity, sensation seeking, or impulsivity and providing them with personality-matched cognitive-behavioral interventions may be helpful in preventing or mitigating prescription drug misuse. Our results point to the specific mental health symptoms that are important to target in each of these personality-matched interventions. Frontiers Media S.A. 2021-04-27 /pmc/articles/PMC8110923/ /pubmed/33986700 http://dx.doi.org/10.3389/fpsyt.2021.640766 Text en Copyright © 2021 Stewart, Chinneck, Thompson, Afzali, Nogueira-Arjona, Mahu and Conrod. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Stewart, Sherry H. Chinneck, Annie Thompson, Kara Afzali, Mohammad H. Nogueira-Arjona, Raquel Mahu, Ioan T. Conrod, Patricia J. Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways |
title | Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways |
title_full | Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways |
title_fullStr | Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways |
title_full_unstemmed | Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways |
title_short | Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways |
title_sort | personality to prescription drug misuse in adolescents: testing affect regulation, psychological dysregulation, and deviance proneness pathways |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110923/ https://www.ncbi.nlm.nih.gov/pubmed/33986700 http://dx.doi.org/10.3389/fpsyt.2021.640766 |
work_keys_str_mv | AT stewartsherryh personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways AT chinneckannie personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways AT thompsonkara personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways AT afzalimohammadh personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways AT nogueiraarjonaraquel personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways AT mahuioant personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways AT conrodpatriciaj personalitytoprescriptiondrugmisuseinadolescentstestingaffectregulationpsychologicaldysregulationanddeviancepronenesspathways |